Researchers from the Medical College of Wisconsin and Johns Hopkins University School of Medicine completed the largest reported high-throughput screen of about 400,000 compounds searching for novel human cytomegalovirus (HCMV) inhibitors, and identified five structurally unique hits showing activity at sub-low micromolar concentrations.